Movement Alert|Oscar Health Rises 7.59% in Regular Trading, Wells Fargo Upgrades Rating to Equal Weight

Market Focus06-04

On June 4, Oscar Health rose 7.59% in regular trading, trading at $23.02/share, with trading volume of $52.94 million. The rally was driven by Wells Fargo upgrading the stock from Underweight to Equal Weight, with a significant price target increase from $11 to $20.

The upgrade sent a positive signal to the market, effectively offsetting negative sentiment from the June 2 announcement that co-founder and CTO Mario Schlosser transitioned out of his CTO role into an advisory position to the CEO. Given that Oscar Health is a technology-driven healthcare company built around a full-stack platform leveraging data and AI, the CTO departure had initially triggered concerns about the continuity of its tech strategy, pushing shares down over 5% on June 2. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean price target of $22.18.

Oscar Health operates as a health insurance company in the United States, offering Individual and Small Group, Medicare Advantage plans, and +Oscar, a technology-driven platform designed to help providers and payors shift to value-based care.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment